Sterility evaluation is a core microbiological assessment that verifies whether medical devices labeled as sterile meet the required Sterility Assurance Level (SAL) before they reach patients. This article explains the applicable standards, sample types, testing items, laboratory methods, and regulatory applications of sterility evaluation for medical devices. It is intended to help manufacturers, regulatory affairs professionals, and quality engineers establish compliant sterility testing programs.
Technical Overview
Sterility evaluation refers to the systematic set of microbiological tests and validation activities used to demonstrate that a medical device labeled as sterile is free from viable microorganisms. Because absolute sterility cannot be proven by testing a finished product alone, sterility is assured through a validated sterilization process combined with a documented Sterility Assurance Level (SAL), typically SAL 10⁻⁶. This means the probability of a single viable microorganaman occurring on a device after sterilization must be no greater than one in one million.
The evaluation framework is built on internationally recognized standards published by ISO, USP, European Pharmacopoeia, and regional standardization bodies:
- ISO 11737-1 — Determination of a population of microorganisms on products (bioburden testing)
- ISO 11737-2 — Sterility tests performed in the definition, validation, and maintenance of a sterilization process
- ISO 11135 — Validation and routine control of ethylene oxide (EO) sterilization
- ISO 11137 (Parts 1, 2, 3) — Sterilization of health care products by radiation
- ISO 17665 — Moist heat sterilization of health care products
- USP Chapter 71 and Ph. Eur. 2.6.1 — Pharmacopoeial sterility test methods
- GB/T 19973 and GB/T 14233.2 — Chinese national standards for microbiological evaluation and sterility testing of medical devices
In practice, sterility evaluation is performed within a quality management system aligned with ISO 13485 and a risk management process aligned with ISO 14971. Testing is typically conducted by accredited third-party laboratories in controlled aseptic environments, such as ISO Class 5 clean air devices conforming to ISO 14644-1, to minimize the risk of false-positive results caused by laboratory contamination.
Testing Samples
Samples submitted for sterility evaluation must be representative of routine production, processed through the fully validated sterilization cycle, and tested in their final primary packaging. Typical sample categories include:
Sterile Single-Use Devices
Hypodermic syringes and needles, intravenous catheters, infusion and transfusion sets, urinary catheters, endotracheal tubes, and other disposable devices sterilized by ethylene oxide, gamma radiation, electron beam, or moist heat.
Implantable Devices
Orthopedic implants such as screws, plates, and joint replacement systems; cardiovascular devices including stents, heart valves, and pacemaker leads; intraocular lenses; and dental implants, where sterility assurance is directly linked to patient safety and clinical outcomes.
Wound Care and Surgical Products
Sterile wound dressings, absorbable and non-absorbable sutures, surgical staplers, hemostatic agents, drapes, gowns, and gloves that require demonstrated sterility throughout their shelf life.
Sterile Diagnostic and Laboratory Consumables
Sterile specimen containers, blood collection tubes, sampling swabs, pipette tips, and single-use laboratory devices intended for aseptic procedures or in vitro diagnostic applications.
Testing Items
A complete sterility evaluation program typically covers the following items, with the specific scope determined by product characteristics, the sterilization modality, and the target regulatory market:
- Sterility test using the membrane filtration method or the direct transfer method
- Bioburden determination (total viable microbial count on products prior to sterilization)
- Bacteriostasis and fungistasis (B/F) validation to confirm the test method can recover microorganisms in the presence of the product
- Bacterial endotoxins test using LAL-based methods, where applicable
- Package seal integrity and microbial barrier verification supporting sterility maintenance, per ISO 11607
- Review of biological indicator performance and sterilization cycle verification data
- Ethylene oxide residual analysis per ISO 10993-7 for EO-sterilized products
Testing Methods
Method selection depends on the physical form of the device, the volume of rinse fluid it can release, and whether the product contains inhibitory substances. All sterility tests use two culture media to detect both bacterial and fungal contamination.
Membrane Filtration Method
The sample is disassembled or rinsed with sterile fluid, and the rinse liquid is passed through a 0.45 µm membrane filter that retains any viable microorganisms. The membrane is aseptically divided and transferred into two media: Fluid Thioglycollate Medium (FTM) incubated at 30–35 °C for aerobic and anaerobic bacteria, and Soybean-Casein Digest Medium (SCDM/TSB) incubated at 20–25 °C for fungi and aerobic microorganisms. Both cultures are incubated for 14 days with periodic visual examination.
Direct Transfer Method
For devices that cannot be filtered, such as dressings, sutures, and large solid components, the sample is immersed directly into FTM and SCDM. Products with hollow lumens are filled with medium to ensure contact with internal surfaces. Incubation conditions and duration match the membrane filtration method, with observations typically performed on days 3, 7, and 14.
Bioburden Determination
Microorganisms are extracted from unsterilized product units using validated recovery methods, enumerated on suitable agar media, and corrected with a recovery factor. Bioburden data are essential for establishing radiation sterilization doses (such as VDmax25) under ISO 11137-2 and for substantiating overkill cycles for EO and moist heat processes.
Controls and Result Interpretation
- Positive controls using reference strains such as Staphylococcus aureus, Clostridium sporogenes, Bacillus subtilis, Candida albicans, and Aspergillus brasiliensis confirm culture medium performance.
- Negative controls verify the sterility of media, diluents, and the testing environment.
- Any turbidity or growth in test containers is considered a positive result unless a documented laboratory investigation demonstrates invalidating laboratory error.
- Growth promotion tests and B/F validation must be completed before routine test results can be accepted.
Applications
Sterility evaluation results support medical device manufacturers throughout the product life cycle, from process development to post-market surveillance:
- Regulatory submissions, including national medical device registration, FDA premarket notifications and approvals, and CE technical documentation under the EU Medical Device Regulation
- Initial validation and periodic requalification of ethylene oxide, radiation, and moist heat sterilization processes
- Routine batch release testing or support for parametric release decisions
- Change control assessments for modifications to materials, packaging, suppliers, or sterilization parameters
- Shelf-life and stability studies verifying that sterility is maintained to the labeled expiry date
- Investigations of contamination complaints, sterilization deviations, and adverse event reports
FAQ
What does SAL 10⁻⁶ mean?
It means the sterilization process must reduce the microbial population so that the probability of finding a single viable microorganism on a device is no greater than one in a million. This is the standard sterility assurance level required for devices intended to contact compromised tissue or enter normally sterile body sites.
Can a finished-product sterility test alone prove that a device is sterile?
No. A sterility test is statistically limited because only a small fraction of a production lot can be sampled. Sterility is primarily assured through a validated sterilization process, with finished-product testing serving as a verification tool rather than the sole basis of assurance.
How many samples are required for a sterility test?
Sample quantities depend on the applicable standard and batch size. Pharmacopoeial methods define minimum test units per lot, while ISO 11737-2 defines sampling for process validation, which typically requires testing across multiple production lots with predetermined acceptance criteria.
How long does a sterility test take?
The standard incubation period is 14 days for both media, plus time for sample preparation, media quality control, and result review. Including method suitability validation, a complete evaluation may take several weeks.
What is the difference between bioburden testing and sterility testing?
Bioburden testing quantifies the microbial population present on a product before sterilization, while sterility testing examines a sterilized product for the absence of viable microorganisms. Bioburden data are used to design and validate the sterilization process, and sterility tests verify its outcome.
When can parametric release replace a routine sterility test?
Parametric release may be accepted when the sterilization process is thoroughly validated, physical process parameters are tightly monitored, and biological indicators demonstrate consistent lethality. Regulatory approval is required before a manufacturer may rely on parametric release instead of end-product sterility testing.
